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Benign acute childhood myositis: an alarming
condition with an excellent prognosis!☆
To the Editor,
Benign acute childhood myositis (BACM) causes difﬁculty to walk
due to severe bilateral calf pain. We report the clinical and laboratory
features of children admitted with BACM to a level II hospital's
pediatric department, from January 2001 to December 2012
(12 years). Data were collected retrospectively from patient's clinical
records. The purpose was to characterize BACM's clinical picture,
providing greater awareness to its benign course and helping to
differentiate it from more serious disorders.
Twenty-eight admissions were identiﬁed (2.5/1000 admissions),
corresponding to 25 children (Table). There was a 4.6:1 male:female
ratio (21 boys, 84%). Median age was 7 years (range, 4-10 years), and
82% were older than 5 years. Most cases were seen from 2008 to 2010
(n = 19, 67.9%) and during winter and spring (n = 20, 71.4%) (Figs. 1
and 2). All occurred at the early convalescent phase of an upper
respiratory infection. History of recent trauma or vigorous exercise and
family history of neuromuscular disorders were negative. On physical
examination at the pediatric emergency department, all patients were
unable to walk/bear weight. Bilateral gastrocnemius-soleus muscles
were tender tomild palpationwithout other inﬂammatory signs. Lower
extremity sensation was intact, with normal strength, tone, and deep
tendon reﬂexes. Children were admitted for clinical and laboratory
follow-up because of serious functional impairment (n= 24, 85.7%) or
previous history of BACM/recurrence (n= 4). The following laboratory
abnormalitieswere detected (Table): leukopenia (n=10), neutropenia
(n = 7), thrombocytopenia (n = 6), and mildly elevated C-reactive
protein (CRP) (n = 2). All children presented a markedly elevated
serum creatine kinase (CK); median admission value was 4181 UI/L
(range, 785-26863 UI/L). In the 22 available aminotransferase results,
aspartate transaminase (AST) was elevated in all, with a less increased
alanine transaminase (ALT) level in 12 cases. Blood urea nitrogen,
creatinine, electrolytes, andurinalysiswerenormal. Serologic testswere
performed in 20 cases (71.4%), with 9 positive results (Table):
Mycoplasma pneumoniae (n = 3), cytomegalovirus and inﬂuenza A
(n = 2), and inﬂuenza B and adenovirus (n = 1).
Median admission period was 3 days (range, 1-7 days), and all
children revealed clinical and laboratory improvement with supportive
therapy (bed rest, intravenous hydration, and oral ibuprofen). No red to
brown urine or renal/hydroelectrolytic abnormalities were seen.
Children with recurrent episodes were reassessed at pediatric consul-
tation 1 month after discharge, with full recovery and normal CK levels.
The remaining patients were referred to their attending physician.
Benign acute childhoodmyositis is a rare disorder and continues to
lead physicians into unnecessary workup when they are unfamiliar
with its presentation [1-5].Most commonly occur after inﬂuenza B and
☆ Conﬂict of interest: None.
occasionally inﬂuenza A infection, but parainﬂuenza, adenovirus,
herpes simplex, Epstein-Barr, Coxsackie, rotavirus, andM pneumoniae
have also been implicated [1-3,5-10], as found in our study. As
evidenced, key elements in the diagnosis are a preceding upper
respiratory infection followed by the acute onset of typical myositis
clinical ﬁndings, predominantly affecting gastrocnemius-soleus mus-
cles. Further clinical features include school-aged boys and late
winter–early spring predominance, elevatedCK, and aminotransferase
levels (especially AST) [1-10]. Transient hematological abnormalities
(mild leukopenia, neutropenia, and thrombocytopenia) are also seen
[1,3,8-10]. Erythrocyte sedimentation rate and CRP are usually normal
but may be mildly elevated [1-3,5,6]. Patients with this typical clinical
presentation can be treated as an outpatient [1,5]. However, as seen in
our study, some children are admitted for hydration, observation, and
serial CK levels to rule out any progression to rhabdomyolysis [1,6,8-
10]. Recurrence is rare and has been demonstrated to be caused by
different viruses or different inﬂuenza types [9]. In our study, 3
children had recurrent episodes with more than a year interval, and
they totally recovered in between. If different etiologic agents were
behind these episodes, it was not possible to assess. Treatment is
supportive, and antivirals are unlikely to be beneﬁcial [2-5]. The
hallmark of BACM is its spontaneous and rapid clinical resolution
within 1 week [1-5]. In this study, all children fully recovered within a
week or less onlywith supportivemeasures. Higher CK levelswere not
associated with acute renal failure, progression to rhabdomyolysis, or
other complications. Patients can be discharged if they have typical
presentation, normal renal function, and follow-up to ensure complete
resolution [2,10]. Further investigation is not indicated unless there is
clinical concern for more serious disorders [1,6,8,10]. Findings not
classically associated with BACM include myoglobinuria, recent
trauma or vigorous exercise, family history of neuromuscular
disorders, subacute or chronic progression, a new rash, frank muscle
weakness, or abnormal neurologic ﬁndings. When such atypical
features are present, other diagnosis as rhabdomyolysis, Guillain-
Barré syndrome, primary inﬂammatorymyositis, muscular dystrophy,
or metabolic disease must be excluded [2,6,8,10].
Benign acute childhood myositis should be part of the broad
differential diagnosis of a child unable to walk/bear weight. Although
potentially alarming, it is self-limited with an excellent prognosis.
Recognition of this rare clinical entity by the emergency physician is
essential to preventunnecessary invasive testing andhospital admission.
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Table
Clinical and laboratory features of 25 children admitted with BACM
Child no. Sex Age (y) Admission main criteria WBC
(×109/L)
ANC
(×109/L)
Platelet count
(×109/L)
CRP
(mg/L)
Admission CK (UI/L) AST
(UI/L)
ALT
(UI/L)
Serology
(IgM+)
Hospital
stay (d)
1 M 7 FI 8.5 N N N 4095 NA NA – 2
2 M 10 FI 3.0 1.341 N N 4369 NA NA – 4
3 M 4 FI 8.1 N N N 4275 NA NA Inﬂuenza B 2
4 M 10 FI 2.6 0.754 N N 6629 428 90 – 2
5 M 7 FI 4.8 N N N 5020 234 56 CMV 3
6 M 6 FI 5.2 N N N 10157 352 69 – 2
7 M 5 FI 4.6 N N N 7125 124 31 – 3
8 M 10 FI 4.6 N N N 2329 103 30 – 2
9 M 10 FI 4.4 N 145 N 6022 288 95 – 2
10 M 7 FI 4.2 1.218 N N 1582 133 29 M. pneum 2
11 F 5 FI 2.4 0.823 145 N 4267 157 52 M. pneum 3
12 M 8 FI 3.8 N N N 1250 59 18 – 2
13 M 5 R 2ndepisode 5.3 N N 25 6790 NA NA Inﬂuenza A 4
14 M 5 FI 6.3 N N N 6466 NA NA CMV 3
15 M 6 FI 5.7 N N 52 3927 141 40 Adenovírus 5
16 M 7 FI 2.6 0.762 63 N 3156 NA NA M. pneum 7
13 M 6 R third episode 5.6 N N N 785 157 71 – 4
17 M 10 FI 3.1 1.240 N N 2815 134 41 – 3
18 M 10 5.5 N N N 2049 149 68 – 4
19 F 8 FI ﬁrst episode 4.2 N 123 N 26863 907 21 – 2
20 M 8 FI 3.3 1.340 N N 1455 79 32 – 2
21 F 6 FI 4.5 N 93 N 3298 117 35 – 3
19 F 9 R second episode 3.9 N 109 N 10979 387 94 Inﬂuenza A 5
22 M 7 FI 5.3 N N N 1064 158 17 – 2
23 M 8 FI ﬁrst episode 5.2 N N N 21492 1070 203 – 6
24 F 8 FI 3.3 N N N 3271 91 29 – 1
25 M 5 FI 3.3 N N N 1851 106 37 – 2
23 M 9 R second episode 5.8 N N N 14453 451 108 – 7
Median abnormal values 3.2 1.218 116 38.5 4181 153 70
Child 13, 19, and 23 presented recurrent episodes (child 13 had a previous episode out of the study period). Bold numbers indicate abnormal values. Reference range: CRP, less than 5
mg/L; CK, 31 to 152 UI/L; AST, less than 31 UI/L; ALT, less than 39 UI/L. Leukopenia: white blood cell count less than 4 × 109/L; neutropenia: absolute neutrophil count less than 1.5 ×
109/L; thrombocytopenia: platelet count less than 150 × 109/L. Viral and bacterial identiﬁcationwas based on serologic tests with a positive immunoglobulinM result. Abbreviations:
ANC, absolute neutrophil count; CMV, cytomegalovirus; F, female; FI, functional impairment; IgM, immunoglobulin M; M, male; M. pneum, Mycoplasma pneumoniae; n, absolute
number; N, normal value; NA, not available; R, recurrence; WBC, white blood cell count.
0
1
2
3
4
5
6
7
8
9
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
N
um
be
r o
f a
dm
itt
ed
 c
as
es
Year
Fig. 1. Annual distribution of admitted cases with BACM. Most cases were seen from
2008 to 2010 (n = 19, 67.9%).
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Fig. 2.Monthly distribution of admitted cases with BACM. Most cases were seen during
winter and spring.
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An intelligent tourniquet system to stop
traumatic extremity bleeding☆,☆☆
To the Editor,
From 2001 to 2013, the science of emergency tourniquet use to
stop traumatic bleeding has resulted in improved casualty survival
rates [1,2]. However, not all casualties are saved who could be saved
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